168 related articles for article (PubMed ID: 14757772)
21. Interaction of von Willebrand factor domain A1 with platelet glycoprotein Ibalpha-(1-289). Slow intrinsic binding kinetics mediate rapid platelet adhesion.
Miura S; Li CQ; Cao Z; Wang H; Wardell MR; Sadler JE
J Biol Chem; 2000 Mar; 275(11):7539-46. PubMed ID: 10713059
[TBL] [Abstract][Full Text] [Related]
22. Site-directed mutagenesis of a soluble recombinant fragment of platelet glycoprotein Ib alpha demonstrating negatively charged residues involved in von Willebrand factor binding.
Murata M; Ware J; Ruggeri ZM
J Biol Chem; 1991 Aug; 266(23):15474-80. PubMed ID: 1651333
[TBL] [Abstract][Full Text] [Related]
23. Modulation by heparin of the interaction of the A1 domain of Von Willebrand factor with glycoprotein Ib.
Perrault C; Ajzenberg N; Legendre P; Rastegar-Lari G; Meyer D; Lopez JA; Baruch D
Blood; 1999 Dec; 94(12):4186-94. PubMed ID: 10590063
[TBL] [Abstract][Full Text] [Related]
24. Regulation of von Willebrand factor binding to the platelet glycoprotein Ib-IX by a membrane skeleton-dependent inside-out signal.
Englund GD; Bodnar RJ; Li Z; Ruggeri ZM; Du X
J Biol Chem; 2001 May; 276(20):16952-9. PubMed ID: 11278380
[TBL] [Abstract][Full Text] [Related]
25. Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex.
Andrews RK; Booth WJ; Gorman JJ; Castaldi PA; Berndt MC
Biochemistry; 1989 Oct; 28(21):8317-26. PubMed ID: 2557900
[TBL] [Abstract][Full Text] [Related]
26. Tyrosine sulfation of glycoprotein I(b)alpha. Role of electrostatic interactions in von Willebrand factor binding.
Dong J; Ye P; Schade AJ; Gao S; Romo GM; Turner NT; McIntire LV; López JA
J Biol Chem; 2001 May; 276(20):16690-4. PubMed ID: 11279169
[TBL] [Abstract][Full Text] [Related]
27. Filamin A binding to the cytoplasmic tail of glycoprotein Ibalpha regulates von Willebrand factor-induced platelet activation.
Feng S; Reséndiz JC; Lu X; Kroll MH
Blood; 2003 Sep; 102(6):2122-9. PubMed ID: 12791664
[TBL] [Abstract][Full Text] [Related]
28. A discontinuous autoinhibitory module masks the A1 domain of von Willebrand factor.
Deng W; Wang Y; Druzak SA; Healey JF; Syed AK; Lollar P; Li R
J Thromb Haemost; 2017 Sep; 15(9):1867-1877. PubMed ID: 28692141
[TBL] [Abstract][Full Text] [Related]
29. Specific electrostatic interactions between charged amino acid residues regulate binding of von Willebrand factor to blood platelets.
Interlandi G; Yakovenko O; Tu AY; Harris J; Le J; Chen J; López JA; Thomas WE
J Biol Chem; 2017 Nov; 292(45):18608-18617. PubMed ID: 28924049
[TBL] [Abstract][Full Text] [Related]
30. Phenotype changes resulting in high-affinity binding of von Willebrand factor to recombinant glycoprotein Ib-IX: analysis of the platelet-type von Willebrand disease mutations.
Tait AS; Cranmer SL; Jackson SP; Dawes IW; Chong BH
Blood; 2001 Sep; 98(6):1812-8. PubMed ID: 11535515
[TBL] [Abstract][Full Text] [Related]
31. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib.
Girma JP; Takahashi Y; Yoshioka A; Diaz J; Meyer D
Thromb Haemost; 1990 Oct; 64(2):326-32. PubMed ID: 1702906
[TBL] [Abstract][Full Text] [Related]
32. Characterization of murine anti-glycoprotein Ib monoclonal antibodies that differentiate between shear-induced and ristocetin/botrocetin-induced glycoprotein Ib-von Willebrand factor interaction.
Cauwenberghs N; Ajzenberg N; Vauterin S; Hoylaerts MF; Declerck PJ; Baruch D; Deckmyn H
Haemostasis; 2000; 30(3):139-48. PubMed ID: 11014964
[TBL] [Abstract][Full Text] [Related]
33. A critical role for 14-3-3zeta protein in regulating the VWF binding function of platelet glycoprotein Ib-IX and its therapeutic implications.
Dai K; Bodnar R; Berndt MC; Du X
Blood; 2005 Sep; 106(6):1975-81. PubMed ID: 15941906
[TBL] [Abstract][Full Text] [Related]
34. Identification of the regulatory elements of the human von Willebrand factor for binding to platelet GPIb. Importance of structural integrity of the regions flanked by the CYS1272-CYS1458 disulfide bond.
Nakayama T; Matsushita T; Dong Z; Sadler JE; Jorieux S; Mazurier C; Meyer D; Kojima T; Saito H
J Biol Chem; 2002 Jun; 277(24):22063-72. PubMed ID: 11943773
[TBL] [Abstract][Full Text] [Related]
35. Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent interactions.
Dong JF; Berndt MC; Schade A; McIntire LV; Andrews RK; López JA
Blood; 2001 Jan; 97(1):162-8. PubMed ID: 11133756
[TBL] [Abstract][Full Text] [Related]
36. Mapping the glycoprotein Ib-binding site in the von willebrand factor A1 domain.
Cruz MA; Diacovo TG; Emsley J; Liddington R; Handin RI
J Biol Chem; 2000 Jun; 275(25):19098-105. PubMed ID: 10764791
[TBL] [Abstract][Full Text] [Related]
37. The membrane-proximal intermolecular disulfide bonds in glycoprotein Ib influence receptor binding to von Willebrand factor.
Mo X; Luo SZ; Munday AD; Sun W; Berndt MC; López JA; Dong JF; Li R
J Thromb Haemost; 2008 Oct; 6(10):1789-95. PubMed ID: 18647229
[TBL] [Abstract][Full Text] [Related]
38. Crystal structure of the von Willebrand Factor A1 domain and implications for the binding of platelet glycoprotein Ib.
Emsley J; Cruz M; Handin R; Liddington R
J Biol Chem; 1998 Apr; 273(17):10396-401. PubMed ID: 9553097
[TBL] [Abstract][Full Text] [Related]
39. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.
Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS
Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340
[TBL] [Abstract][Full Text] [Related]
40. Recombinant von Willebrand factor Arg578-->Gln. A type IIB von Willebrand disease mutation affects binding to glycoprotein Ib but not to collagen or heparin.
Randi AM; Jorieux S; Tuley EA; Mazurier C; Sadler JE
J Biol Chem; 1992 Oct; 267(29):21187-92. PubMed ID: 1400429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
